- Home
- VRTX vs SHW Comparison
VRTX vs SHW Comparison
Compare VRTX & SHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRTX | SHW |
|---|---|---|
| Founded | 1989 | 1866 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | RETAIL: Building Materials |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.7B | 81.7B |
| IPO Year | 2006 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VRTX | SHW |
|---|---|---|
| Price | $492.65 | $322.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 13 |
| Target Price | ★ $536.24 | $389.15 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 05-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | ★ 836.54 | N/A |
| EPS | ★ 15.32 | 10.26 |
| Revenue | $2,488,652,000.00 | ★ $17,900,800,000.00 |
| Revenue This Year | $10.79 | $5.22 |
| Revenue Next Year | $10.14 | $4.59 |
| P/E Ratio | $32.63 | ★ $32.25 |
| Revenue Growth | ★ 46.20 | 2.09 |
| 52 Week Low | $362.50 | $308.84 |
| 52 Week High | $519.68 | $379.65 |
Technical Indicators
Market Signals| Indicator | VRTX | SHW |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 28.85 |
| Support Level | $428.47 | N/A |
| Resistance Level | $503.88 | $345.06 |
| Average True Range (ATR) | 15.98 | 8.66 |
| MACD | 1.00 | -4.56 |
| Stochastic Oscillator | 66.35 | 2.13 |
Price Performance
Historical ComparisonAbout VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About SHW Sherwin-Williams Company (The)
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 4,800 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.